Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
letter
. 2019 Jul 15;66(5):437–438. doi: 10.1111/zph.12583

Failure to detect MERS‐CoV RNA in urine of naturally infected dromedary camels

Elmoubasher A Farag 1,2, Bart L Haagmans 2, Hamad Al‐Romaihi 1, Khaled Mohran 3,4, Mohamed Haroun 3, Ahmed M El‐Sayed 1, Marion Koopmans 2, Mohammed AlHajri 1,, Chantal B E M Reusken 2,5
PMCID: PMC7165863  PMID: 31305027

To The Editor:

Dromedaries (Camelus dromedarius) are reservoirs for zoonotic transmission of Middle East respiratory syndrome coronavirus (MERS‐CoV), but even six years after its discovery, the transmission route(s) of MERS‐CoV from dromedaries to humans has not been fully elucidated.

The World Health Organization recommends that groups at high risk for severe MERS should avoid contact with dromedary camels, consumption of raw camel milk or camel urine, as well as eating meat that has not been properly cooked (WHO, 2019). Although MERS‐CoV RNA has been detected in dromedary camel nasal secretions, saliva, faeces and milk (Farag et al., 2015; Haagmans et al., 2015; Reusken et al., 2014), and in human urine samples (Corman et al., 2016), so far no evidence has been obtained for the presence of the virus in dromedary urine (Adney et al., 2014; Ali et al., 2017). However, it has been speculated that, amongst others, collection and consumption of urine from acutely infected camels might create circumstances for cross‐species transmission event (Gossnere et al., 2016; MacKay, 2015). Dromedary camel urine plays an ancient traditional and religious role in daily life in the Middle East and North Africa region as well as in parts of Asia. Camel urine is believed to have therapeutic effects in the treatment of cancer, diabetes, certain infectious and cardiovascular diseases as well as in the treatment of hair and skin problems. Hence, fresh urine is consumed, used to wash body and hair, and is a component in ointments (Alkhamees, 2017; Gader, 2016) for example it has been described that Bedouins in the Middle East have a daily consumption of 100 ml camel urine while a study amongst 156 Saudi cancer patients showed that 15.7% drank camel urine (Abuelgasim, 2018; Al‐Yousef et al., 2012).

Here, we investigated the presence of MERS‐CoV RNA and specific antibodies in urine of camels that were offered for slaughter at the central slaughterhouse in Doha, Qatar in March 2014. Qatar has reported 19 MERS cases as of August 2018 (WHO, 2019). Camels at the Doha slaughterhouse were shown to have a high prevalence of MERS‐CoV RNA shedding. A previous study showed that 59% of the camels had evidence for virus shedding in at least one type of swab at the time of slaughter (Farag, 2014). Urine from 23 camels, aged 4 months to 10 years (median 6 months), was collected aseptically post‐slaughter from intact bladders using 20 ml syringes. The collected urine was stored at −80°C until RNA extraction as described before (Reusken, 2014). The urine was analysed for the presence of MERS‐CoV using a screening RT‐PCR targeting the UpE region and a confirmatory RT‐PCR targeting the N‐gene as described before (Farag, 2015). We interpreted the urine results in the context of the presence of MERS‐CoV RNA and antibodies in each respectively same‐time collected nasal swab and serum sample (data in Farag, 2015). In none of the 23 urine samples, MERS‐CoV RNA could be detected while of the corresponding 23 nasal swabs 11 camels tested positive using both tests. The same urine samples were analysed for the presence of MERS‐CoV‐specific antibodies using micro‐array technology (Reusken, Haagmans, et al., 2013; Reusken, Mou, et al., 2013). We found MERS‐CoV specific antibodies in 16 of 23 urine samples while all camels showed such evidence for a (previous) MERS‐CoV infection in serum. Based on the observed relative fluorescence, the overall reactivity of the antibodies in sera was higher than of those present in urine (Data not shown). The specificity of the antibodies detected in the serum samples was confirmed by virus neutralization (Reusken, Haagmans, et al., 2013).

Although 11 camels showed evidence for an acute MERS‐CoV infection at the time of urine sampling and all camels showed evidence for a (past) infection based on the presence of antibodies in serum, we found no evidence for shedding of MERS‐CoV RNA in urine. These results are in line with data obtained from another field study and experimentally infected dromedaries, indicating the absence of MERS‐CoV in camel urine (Adney, 2014; Ali, 2017). It should be noted that failure to detect the virus in urine in the former field investigation (Ali, 2017), in contrast to our study, was not linked to dromedaries with MERS‐CoV RNA in their nasal swab. Together the studies imply the absence of a role of camel urine in MERS‐CoV transmission to humans. However, to establish unequivocally that urine does not play a role in zoonotic transmission of MERS‐CoV a large cohort study may be needed including animals of different age groups and at different stages of infection with simultaneous and longitudinal sampling of urine, serum and swabs. In the absence of results of such a systematic study, prudence towards consumption of raw camel urine is still indicated.

CONFLICT OF INTEREST

The authors declare that there is no conflict of interest.

ACKNOWLEDGEMENTS

We are indebted to Erwin de Bruin, Jolanda Maaskant, Stalin Raj and the Doha abattoir veterinarians for excellent technical support. A thanks is also extended to the Ministry of Public Health and Animal Resources authorities facilitating this report. Sampling was done under protocol 2014‐01‐001 of the Qatar Institutional Animal Care and Use Committee (IACUC).

Farag EA, Haagmans BL, Al‐Romaihi HE, et al. Failure to detect MERS‐CoV RNA in urine of naturally infected dromedary camels. Zoonoses Public Health. 2019;66:437–438. 10.1111/zph.12583

REFERENCES

  1. Abuelgasim, K. A. , Alsharhan, Y. , Alenzi, T. , Alhazzani, A. , Ali, Y. Z. , & Jazieh, A. R. (2018). The use of complementary and alternative medicine by patients with cancer: A cross‐sectional survey in Saudi Arabia. BMC Complementary and Alternative Medicine, 18, 88–96. 10.1186/s12906-018-2150-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adney, D. R. , van Doremalen, N. , Brown, V. R. , Bushmaker, T. , Scott, D. , & de Wit, E. (2014). Replication and shedding of MERS‐CoV in upper respiratory tract of inoculated dromedary camels. Emerging Infectious Diseases, 20, 1999–2005. 10.3201/eid2012.141280 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ali, M. A. , Shehata, M. M. , Gomaa, M. R. , Kandeil, A. , El‐Shesheny, R. , & Kayed, A. S. (2017). Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt. Emerging Microbes and Infection, 6, e1 10.1038/emi.2016.130 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Alkhamees, O. A. , & Alsanad, S. M. (2017). A review of the therapeutic characteristics of camel urine. African Journal of Traditional, Complementary and Alternative Medicines, 14, 120–126. 10.21010/ajtcam.v14i6.12 [DOI] [Google Scholar]
  5. Al‐Yousef, N. , Gaafar, A. , Al‐Otaibi, B. , Al‐Jammaz, I. , Al‐Hussein, K. , & ABoussekhra, A. (2012). Camel urine components display anti‐cancer properties in vitro. Journal of Ethnopharmacology, 143, 819–825. 10.1016/j.jep.2012.07.042 [DOI] [PubMed] [Google Scholar]
  6. Corman, V. M. , Albarrak, A. M. , Omrani, A. S. , Albarrak, M. M. , Farah, M. E. , & Almasri, M. (2016). Viral shedding and antibody response in 37 patients with middle east respiratory syndrome coronavirus infection. Clinical Infectious Diseases, 15, 477–483. 10.1093/cid/civ951 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Farag, E. , Reusken, C. , Haagmans, B. , Mohran, K. , Raj, V. S. , & Pas, S. (2015). High proportion of MERS‐CoV shedding dromedaries at slaughterhouse with potential epidemiological link to human cases, Qatar 2014. Infection Ecology and Epidemiology, 5, 28305 10.3402/iee.v5.28305 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gader, A. G. M. A. , & Alhaider, A. A. (2016). The unique medicinal properties of camel products: A review of the scientific evidence. Journal of Taibah University Medical Sciences, 11, 98–103. 10.1016/j.jtumed.2015.12.007 [DOI] [Google Scholar]
  9. Gossner, C. , Danielson, N. , Gervelmeyer, A. , Berthe, F. , Faye, B. , & Kaasik, A. K. (2016). Human‐dromedary camel interactions and the risk of acquiring zoonotic middle east respiratory syndrome coronavirus infection. Zoonoses Public Health, 63, 1–9. 10.1111/zph.12171 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Haagmans, B. L. , van den Brand, J. M. , Raj, V. S. , Volz, A. , Wohlsein, P. , & Smits, S. L. (2015). An orthopoxvirus‐based vaccine reduces virus excretion after MERS‐CoV infection in dromedary camels. Science, 351, 77–81. 10.1126/science.aad1283 [DOI] [PubMed] [Google Scholar]
  11. Mackay, I. M. , & Arden, K. E. (2015). Middle East respiratory syndrome: An emerging coronavirus infection tracked by the crowd. Virus Research, 202, 60–88. 10.1016/j.virusres.2015.01.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Reusken, C. B. , Farag, E. A. , Jonges, M. , Godeke, G. J. , El‐Sayed, A. M. , & Pas, S. D. (2014). Middle East respiratory syndrome coronavirus (MERS‐CoV) RNA and neutralising antibodies in milk collected according to local customs from dromedary camels, Qatar, April 2014. Eurosurveillance, 19, 20829. [DOI] [PubMed] [Google Scholar]
  13. Reusken, C. B. , Haagmans, B. L. , Muller, M. A. , Gutierrez, C. , Godeke, G. J. , & Meyer, B. (2013). Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: A comparative serological study. The Lancet Infectious Diseases, 13, 859–866. 10.1016/S1473-3099(13)70164-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Reusken, C. , Mou, H. , Godeke, G. J. , van der Hoek, L. , Meyer, B. , & Muller, M. A. (2013). Specific serology for emerging human coronaviruses by protein microarray. Eurosurveillance, 18, 20441. [DOI] [PubMed] [Google Scholar]
  15. WHO . (2019). WHO MERS Global Summary and Assessment of Risk, August 2018. Retrieved from: https://www.who.int/csr/disease/coronavirus_infections/risk-assessment-august-2018.pdf

Articles from Zoonoses and Public Health are provided here courtesy of Wiley

RESOURCES